Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 6, Pages e002435
Publisher
BMJ
Online
2021-06-26
DOI
10.1136/jitc-2021-002435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum
- (2020) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
- (2020) G.R. Oxnard et al. ANNALS OF ONCOLOGY
- Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study
- (2020) Frank B. Cortazar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition
- (2020) Amanda D. Bucheit et al. MELANOMA RESEARCH
- It Is Time to Talk About Fertility and Immunotherapy
- (2020) Narjust Duma et al. ONCOLOGIST
- Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
- (2020) Takumi Onoyama et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect
- (2020) J. Boegeholz et al. BMC CANCER
- Checkpoint Inhibitor–Associated Arthritis
- (2020) Nilasha Ghosh et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- MRI Findings of Immune Checkpoint Inhibitor–Induced Hypophysitis: Possible Association with Fibrosis
- (2020) R. Kurokawa et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
- (2020) Yuli Guzman-Prado et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
- (2020) Yi-Te Huang et al. Frontiers in Neurology
- Checkpoint inhibitor-related renal vasculitis and use of rituximab
- (2020) Omar Mamlouk et al. Journal for ImmunoTherapy of Cancer
- Chronic immune checkpoint inhibitor pneumonitis
- (2020) Jarushka Naidoo et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitor-associated celiac disease
- (2020) Yousef Badran et al. Journal for ImmunoTherapy of Cancer
- Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor–Related Cholangiohepatitis
- (2020) Laura Moi et al. Journal of Thoracic Oncology
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
- (2020) Jamie S Lin et al. Journal for ImmunoTherapy of Cancer
- Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
- (2020) Bairavi Shankar et al. JAMA Oncology
- Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
- (2020) Jennifer Cautela et al. Journal for ImmunoTherapy of Cancer
- The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms
- (2019) Julienne E. Bower CANCER
- A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
- (2019) Patrick Arnaud-Coffin et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review
- (2019) Claire Rempenault et al. ARTHRITIS CARE & RESEARCH
- Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
- (2019) Omar Mamlouk et al. Journal for ImmunoTherapy of Cancer
- Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
- (2019) Ulrich Keilholz et al. Journal for ImmunoTherapy of Cancer
- Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
- (2019) Hao Chi Zhang et al. Journal for ImmunoTherapy of Cancer
- Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma
- (2019) Constantin A Dasanu JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Hematologic Complications of Immune Checkpoint Inhibitors
- (2019) Elizabeth J. Davis et al. ONCOLOGIST
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester
- (2019) Wen Xu et al. MELANOMA RESEARCH
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Rituximab Therapy in Patients with Bullous Pemphigoid: A Retrospective Study of 20 Patients
- (2019) Maxim Polansky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
- (2019) Celeste Lebbé et al. JOURNAL OF CLINICAL ONCOLOGY
- A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors
- (2019) Jeroen de Filette et al. HORMONE AND METABOLIC RESEARCH
- Immune checkpoint blockade for organ transplant patients with advanced cancer
- (2019) Pauline De Bruyn et al. CURRENT OPINION IN ONCOLOGY
- The Relationship between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients with Advanced Non-Small Cell Lung Cancer
- (2019) Khinh Ranh Voong et al. Clinical Lung Cancer
- Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition
- (2019) Vylyny Chat et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
- (2019) Paul La Rosée et al. BLOOD
- Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy
- (2019) Xi Chen et al. CLINICAL NEUROPHYSIOLOGY
- Immune checkpoint inhibitor–associated hypophysitis—World Health Organisation VigiBase report analysis
- (2019) Elisa Guerrero et al. EUROPEAN JOURNAL OF CANCER
- Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain
- (2019) Terence T. Sio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
- (2019) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy
- (2019) Blake M. Warner et al. ONCOLOGIST
- Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors
- (2019) Tenglong Tang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
- (2019) Yucai Wang et al. JAMA Oncology
- Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
- (2019) Douglas B. Johnson et al. Journal for ImmunoTherapy of Cancer
- Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
- (2019) Jonathan D. Schoenfeld et al. Journal for ImmunoTherapy of Cancer
- Kidney Complications of Immune Checkpoint Inhibitors: A Review
- (2019) Roman Shingarev et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
- (2019) Jeroen M.k. de Filette et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma
- (2019) Erika F. Rodriguez et al. HUMAN PATHOLOGY
- Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
- (2019) Pooja H. Rambhia et al. International Journal of Clinical Oncology
- Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
- (2019) Hamzah Abu-Sbeih et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Outcomes of Immune-Related Cutaneous Adverse Events
- (2019) Gregory S. Phillips et al. JOURNAL OF CLINICAL ONCOLOGY
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
- (2019) Julia Lai-Kwon et al. Journal of Cancer Survivorship
- Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
- (2019) Audrey Simonaggio et al. JAMA Oncology
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
- (2019) Ezra E. W. Cohen et al. Journal for ImmunoTherapy of Cancer
- Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
- (2019) Marcus A. Couey et al. Journal for ImmunoTherapy of Cancer
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement
- (2019) Catherine R. Sears et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis
- (2019) S. R. Rathinam et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
- (2019) Karthik Suresh et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors
- (2019) Inbar Finkel et al. JOURNAL OF IMMUNOTHERAPY
- Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
- (2019) Divyanshu Dubey et al. NEUROLOGY
- Early infliximab in life-threatening immune-mediated pneumonitis
- (2019) T Cooksley et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
- (2019) Michael C. Sneller et al. Science Translational Medicine
- The importance of early identification of infusion-related reactions to monoclonal antibodies
- (2019) Macarena C Cáceres et al. Therapeutics and Clinical Risk Management
- Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
- (2019) Alberto Vogrig et al. Neurology-Neuroimmunology & Neuroinflammation
- 1775PIncidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience
- (2019) L Gutiérrez Sainz et al. ANNALS OF ONCOLOGY
- The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
- (2019) Harish Seethapathy et al. Clinical Journal of the American Society of Nephrology
- Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer
- (2019) Karthik Suresh et al. Clinical Lung Cancer
- Morphological spectrum of immune checkpoint inhibitor therapy associated gastritis
- (2019) Melanie Johncilla et al. HISTOPATHOLOGY
- Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
- (2019) Alessio Cortellini et al. Journal of Translational Medicine
- Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade
- (2019) Jessica Galant-Swafford et al. ONCOLOGY
- Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
- (2019) Houssein Safa et al. Journal for ImmunoTherapy of Cancer
- Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab
- (2019) Chanakyaram A Reddy et al. Immunotherapy
- Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
- (2019) Hamzah Abu-Sbeih et al. JOURNAL OF CLINICAL ONCOLOGY
- Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
- (2019) Guillaume Manson et al. Journal for ImmunoTherapy of Cancer
- The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
- (2019) Brian I. Rini et al. Journal for ImmunoTherapy of Cancer
- Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease
- (2018) Noha Abdel-Wahab et al. ANNALS OF INTERNAL MEDICINE
- Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials
- (2018) Karen Kelly et al. CANCER
- Vasculitis associated with immune checkpoint inhibitors—a systematic review
- (2018) Anisha Daxini et al. CLINICAL RHEUMATOLOGY
- Long-Term Effects of Lifestyle Intervention and Metformin during DPP on Appendicular Lean Mass
- (2018) ANN V. SCHWARTZ et al. DIABETES
- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Bone marrow histomorphologic criteria can accurately diagnose hemophagocytic lymphohistiocytosis
- (2018) Eric Gars et al. HAEMATOLOGICA
- Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
- (2018) Yinghong Wang et al. INFLAMMATORY BOWEL DISEASES
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
- (2018) Jinhyun Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
- (2018) Wei-Shen Chen et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
- (2018) Fa-Ping Wang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy
- (2018) Jacob Siegel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity
- (2018) John A. Thompson Journal of the National Comprehensive Cancer Network
- Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
- (2018) Sara Valpione et al. Journal of Translational Medicine
- Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
- (2018) Giuseppe Giaccone et al. LANCET ONCOLOGY
- Pembrolizumab-induced acute thrombosis
- (2018) Kei Kunimasa et al. MEDICINE
- Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
- (2018) Sandhya Manohar et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis
- (2018) Sunita M. C. De Sousa et al. Pituitary
- CHECKPOINT INHIBITOR IMMUNE THERAPY
- (2018) Lauren A. Dalvin et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy
- (2018) Mauricio Burotto et al. SEMINARS IN ONCOLOGY
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab
- (2018) Kanako Sakurai et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Bone marrow histomorphologic criteria can accurately diagnose hemophagocytic lymphohistiocytosis
- (2018) Eric Gars et al. HAEMATOLOGICA
- Safety and Efficacy of Retreating with Immunotherapy After Immune-Related Adverse Events in Patients with NSCLC
- (2018) Fernando Costa Santini et al. Cancer Immunology Research
- Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
- (2018) Chun-Bing Chen et al. Cancer Management and Research
- EGFR–TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non–Small Cell Lung Cancer
- (2018) Yasuo Oshima et al. JAMA Oncology
- An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
- (2018) Ryan J. Sullivan et al. Journal for ImmunoTherapy of Cancer
- Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab
- (2018) Fanny Zulay Acero Brand et al. Journal for ImmunoTherapy of Cancer
- Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
- (2018) Yinghong Wang et al. Journal for ImmunoTherapy of Cancer
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
- (2018) Julie R. Brahmer et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitor therapy-induced hypophysitis ∼ a case series of Taiwanese patients
- (2018) Chia-Hung Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Pneumonitis in Non-Small Cell Lung Cancer patients receiving Immune Checkpoint Immunotherapy: incidence and risk factors
- (2018) Karthik Suresh et al. Journal of Thoracic Oncology
- Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer
- (2018) Muhammad Khan et al. MEDICINE
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
- (2018) Priyanka C. Iyer et al. THYROID
- Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
- (2018) Haritha G. Reddy et al. Clinical and Translational Gastroenterology
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
- (2018) Guacimara Ortega Sanchez et al. Journal for ImmunoTherapy of Cancer
- Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
- (2018) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
- (2018) Alvaro Moreira et al. EUROPEAN JOURNAL OF CANCER
- Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review
- (2018) Georges E. Tanios et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IASP classification of chronic pain for ICD-11
- (2018) Michael I. Bennett et al. PAIN
- Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
- (2018) Laura C Cappelli et al. RHEUMATOLOGY
- Checkpoint inhibitors: What gastroenterologists need to know
- (2018) Monjur Ahmed WORLD JOURNAL OF GASTROENTEROLOGY
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
- (2018) Michael D. Tharp et al. JAMA Dermatology
- Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
- (2018) Nicolas Delanoy et al. Lancet Haematology
- Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
- (2018) Shazli Azmi et al. Diabetes Therapy
- Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
- (2018) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
- (2018) Norbaini Abdol Razak et al. Cancers
- Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
- (2018) Karthik Suresh et al. Journal of Thoracic Oncology
- Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
- (2018) Neal Ready et al. Journal of Thoracic Oncology
- Endocrine side effects of cancer immunotherapy
- (2017) Priscilla Cukier et al. ENDOCRINE-RELATED CANCER
- Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
- (2017) Ralf Gutzmer et al. EUROPEAN JOURNAL OF CANCER
- Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies
- (2017) Alice Bernard-Tessier et al. EUROPEAN JOURNAL OF CANCER
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
- (2017) S. Cuzzubbo et al. EUROPEAN JOURNAL OF CANCER
- Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
- (2017) Sébastien Le Burel et al. EUROPEAN JOURNAL OF CANCER
- Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
- (2017) Omar Abdel-Rahman et al. Expert Review of Anticancer Therapy
- Rational management approach to pure red cell aplasia
- (2017) Suresh Kumar Balasubramanian et al. HAEMATOLOGICA
- Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
- (2017) Hisato Kawakami et al. INVESTIGATIONAL NEW DRUGS
- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities
- (2017) Clélia Coutzac et al. Journal of Crohns & Colitis
- Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy
- (2017) Karina L. Vivar et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report
- (2017) Shigeki Numata et al. JOURNAL OF DERMATOLOGY
- Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab
- (2017) Yutaka Kuwatsuka et al. JOURNAL OF DERMATOLOGY
- Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
- (2017) Kendrick Co Shih et al. Journal of Inflammation-London
- Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis
- (2017) Julia Dai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Double-Blind, Randomized, Placebo-Controlled Trial ofPanax Ginsengfor Cancer-Related Fatigue in Patients With Advanced Cancer
- (2017) Sriram Yennurajalingam et al. Journal of the National Comprehensive Cancer Network
- Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report
- (2017) Takeshi Uenami et al. LUNG CANCER
- Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature
- (2017) Juan Ruiz-Bañobre et al. LUNG CANCER
- Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy
- (2017) Mei Fang Zeng et al. MEDICINE
- Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination
- (2017) Jeremy Lupu et al. MELANOMA RESEARCH
- A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles after Combination Therapy with Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer
- (2017) William Carrera et al. NEURO-OPHTHALMOLOGY
- Inflammatory Orbitopathy Associated With Ipilimumab
- (2017) Claire A. Sheldon et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Effects of acupuncture on cancer-related fatigue: a meta-analysis
- (2017) Yan Zhang et al. SUPPORTIVE CARE IN CANCER
- Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial
- (2017) Chien-shan Cheng et al. SUPPORTIVE CARE IN CANCER
- Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments
- (2017) Benedetta Terziroli Beretta-Piccoli et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Arthritis after cancer immunotherapy: symptom duration and treatment response
- (2017) Melanie H. Smith et al. ARTHRITIS CARE & RESEARCH
- Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
- (2017) Laura C. Cappelli et al. ARTHRITIS CARE & RESEARCH
- Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature
- (2017) Hiroshi Takeyama et al. Oncology Letters
- Rational management approach to pure red cell aplasia
- (2017) Suresh Kumar Balasubramanian et al. HAEMATOLOGICA
- Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
- (2017) Marlene Garcia-Neuer et al. Cancer Immunology Research
- The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors
- (2017) Heinz Läubli et al. OncoImmunology
- Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis
- (2017) Daniel Y. Wang et al. OncoImmunology
- Nivolumab-induced aplastic anemia: A case report and literature review
- (2017) Rachel R Comito et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
- (2017) Karen M. Mustian et al. JAMA Oncology
- Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
- (2017) Ashish M. Kamat et al. Journal for ImmunoTherapy of Cancer
- Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
- (2017) Eileen Shiuan et al. Journal for ImmunoTherapy of Cancer
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
- (2017) M. K. Callahan et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of treatment guidance on diarrhea and colitis across ipilimumab studies.
- (2017) S. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash
- (2017) Neelima N. Nallapaneni et al. Journal of the National Comprehensive Cancer Network
- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
- (2016) Anushree C. Shirali et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature
- (2016) L. Spain et al. ANNALS OF ONCOLOGY
- Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury.
- (2016) F. Gelsomino et al. ANNALS OF ONCOLOGY
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
- (2016) Laura C Cappelli et al. ANNALS OF THE RHEUMATIC DISEASES
- Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
- (2016) Alfred Basilious et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
- (2016) M. Nishino et al. CLINICAL CANCER RESEARCH
- Cyclosporine for Dry Eye Associated With Nivolumab
- (2016) Alexander T. Nguyen et al. CORNEA
- A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304)
- (2016) R.C. Miller et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab
- (2016) Ryota Tanaka et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
- (2016) Stefan R. Bornstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
- (2016) L. Marthey et al. Journal of Crohns & Colitis
- Pembrolizumab-triggered Uveitis
- (2016) Stefan Diem et al. JOURNAL OF IMMUNOTHERAPY
- Toxic Epidermal Necrolysis–like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma
- (2016) Namrata Nayar et al. JOURNAL OF IMMUNOTHERAPY
- Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort
- (2016) Shelley Ji Eun Hwang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinical practice guidelines for oral management of Sjögren disease
- (2016) Domenick T. Zero et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab
- (2016) Claire F. Friedman et al. JNCI-Journal of the National Cancer Institute
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
- (2016) Frank B. Cortazar et al. KIDNEY INTERNATIONAL
- Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma – Case Series and Review
- (2016) F. Fierz et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial
- (2016) Michael Benatar et al. MUSCLE & NERVE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Case of Nivolumab-Induced Myositis
- (2016) E. Fox et al. ONCOLOGIST
- A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
- (2016) Kirollos S. Hanna PHARMACOTHERAPY
- Nivolumab-associated acute glomerulonephritis: a case report and literature review
- (2016) Kyungsuk Jung et al. BMC Nephrology
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy
- (2016) Masahide Okamoto et al. Journal of Diabetes Investigation
- Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy
- (2016) Veronica J. Shi et al. JAMA Dermatology
- Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
- (2016) Camille Hua et al. JAMA Dermatology
- Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab
- (2016) Claire F. Friedman et al. JNCI-Journal of the National Cancer Institute
- Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
- (2016) J. Naidoo et al. Cancer Immunology Research
- High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis
- (2016) Siraj Mithoowani et al. Lancet Haematology
- Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
- (2016) Mizuki Nishino et al. JAMA Oncology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Acute visual loss after ipilimumab treatment for metastatic melanoma
- (2016) Melissa A. Wilson et al. Journal for ImmunoTherapy of Cancer
- Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
- (2015) H Wang et al. ACTA DERMATO-VENEREOLOGICA
- Immune therapy in autoimmune encephalitis: a systematic review
- (2015) Margherita Nosadini et al. Expert Review of Neurotherapeutics
- Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis
- (2015) Mahmoud H. Mosli et al. INFLAMMATORY BOWEL DISEASES
- Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review
- (2015) J. Kopecky et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma
- (2015) Douglas B. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety of Infusing Ipilimumab Over 30 Minutes
- (2015) Parisa Momtaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
- (2015) Hansje-Eva Teulings et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy
- (2015) Erik Letko et al. OPHTHALMOLOGY
- Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab
- (2015) David R. Minor et al. Pigment Cell & Melanoma Research
- Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights
- (2015) Alexander Faje Pituitary
- Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia
- (2015) Johanna Kulpa et al. WIENER KLINISCHE WOCHENSCHRIFT
- Immune therapy in autoimmune encephalitis: a systematic review
- (2015) Margherita Nosadini et al. Expert Review of Neurotherapeutics
- Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
- (2015) Ahmad A. Tarhini et al. Journal for ImmunoTherapy of Cancer
- Kidney injuries related to ipilimumab
- (2014) Hassane Izzedine et al. INVESTIGATIONAL NEW DRUGS
- Randomized Controlled Trial of a Cognitive-Behavioral Therapy Plus Hypnosis Intervention to Control Fatigue in Patients Undergoing Radiotherapy for Breast Cancer
- (2014) Guy H. Montgomery et al. JOURNAL OF CLINICAL ONCOLOGY
- Modafinil for the Treatment of Fatigue in Lung Cancer: Results of a Placebo-Controlled, Double-Blind, Randomized Trial
- (2014) Anna Spathis et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
- (2014) Julienne E. Bower et al. JOURNAL OF CLINICAL ONCOLOGY
- Pain in Cancer Survivors
- (2014) Paul A. Glare et al. JOURNAL OF CLINICAL ONCOLOGY
- Managing xerostomia and salivary gland hypofunction
- (2014) Jacqueline M. Plemons et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
- (2014) Jacqueline Jonklaas et al. THYROID
- The Effect of Yoga Exercise on Improving Depression, Anxiety, and Fatigue in Women With Breast Cancer
- (2014) Chao-Jung Taso et al. Journal of Nursing Research
- Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
- (2014) Joshua S Manusow et al. Journal for ImmunoTherapy of Cancer
- Organizing Pneumonia as a Side Effect of Ipilimumab Treatment of Melanoma
- (2013) Igor Z. Barjaktarevic et al. CHEST
- Systematic Monitoring and Treatment of Physical Symptoms to Alleviate Fatigue in Patients With Advanced Cancer: A Randomized Controlled Trial
- (2013) Pleun J. de Raaf et al. JOURNAL OF CLINICAL ONCOLOGY
- Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
- (2013) D. L. Barton et al. JNCI-Journal of the National Cancer Institute
- Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
- (2013) Antoni Ribas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-induced autoimmune adrenalitis
- (2013) Le Min et al. Lancet Diabetes & Endocrinology
- Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
- (2013) Arjun Muralidharan et al. INFLAMMOPHARMACOLOGY
- 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
- (2012) Bhaskar Dasgupta et al. ANNALS OF THE RHEUMATIC DISEASES
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
- (2012) V. L. Patel et al. BLOOD
- Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications
- (2012) Julienne E. Bower et al. BRAIN BEHAVIOR AND IMMUNITY
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
- (2012) Peter A Banks et al. GUT
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
- (2011) H. Trottestam et al. BLOOD
- Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
- (2011) Evelyn Sarnes et al. CLINICAL THERAPEUTICS
- Hemophilia A Induced by Ipilimumab
- (2011) Julie Delyon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods
- (2010) J. A. Reese et al. BLOOD
- Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance
- (2010) C. Moreno et al. BLOOD
- The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials
- (2010) Yuan-Han Qin et al. BLOOD COAGULATION & FIBRINOLYSIS
- Epidemiology and pathophysiology of cancer-associated thrombosis
- (2010) S Noble et al. BRITISH JOURNAL OF CANCER
- Low-dose rituximab in adult patients with primary immune thrombocytopenia
- (2010) Francesco Zaja et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
- (2010) Amanda R. Moraska et al. JOURNAL OF CLINICAL ONCOLOGY
- A Systematic Review of the Treatment of Nausea and/or Vomiting in Cancer Unrelated to Chemotherapy or Radiation
- (2010) Mellar P. Davis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer
- (2010) Miiru IZUMI et al. RESPIROLOGY
- Venous thromboembolism and prognosis in cancer
- (2010) Alok A. Khorana THROMBOSIS RESEARCH
- Treatment of Polymyalgia Rheumatica
- (2009) José Hernández-Rodríguez ARCHIVES OF INTERNAL MEDICINE
- Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer
- (2009) Maxine de la Cruz et al. CANCER
- Tetrada of the possible mycophenolate mofetil embryopathy: A review☆
- (2009) Paul Merlob et al. REPRODUCTIVE TOXICOLOGY
- Even Low Dose of Mycophenolate Mofetil in a Mother Recipient of Heart Transplant Can Seriously Damage the Fetus
- (2009) José Henrique Andrade Vila et al. TRANSPLANTATION
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With CancerA Systematic Review and Meta-analysis
- (2008) Elie A. Akl ARCHIVES OF INTERNAL MEDICINE
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
- (2008) Alberto Alonso-Ruiz et al. BMC MUSCULOSKELETAL DISORDERS
- Autoimmune thrombocytopenia in non-Hodgkin's lymphomas
- (2008) A. W. Hauswirth et al. HAEMATOLOGICA
- Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
- (2008) Elie A Akl et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis
- (2008) E. González et al. KIDNEY INTERNATIONAL
- The Ashwell receptor mitigates the lethal coagulopathy of sepsis
- (2008) Prabhjit K Grewal et al. NATURE MEDICINE
- Cancer-related fatigue: A systematic and meta-analytic review of non-pharmacological therapies for cancer patients.
- (2008) Maria Kangas et al. PSYCHOLOGICAL BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started